Patents by Inventor Seung-Jun Oh

Seung-Jun Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11687074
    Abstract: The present disclosure relates to technology that controls a remote moving body based on collaboration between the moving body and human, and a method for controlling a moving body includes acquiring a first biosignal indicating an intention to start operation of the moving body from a user, operating the moving body, determining a surrounding situation of the moving body that autonomously controls the driving, providing the user with surrounding information of the moving body for inducing path setting, acquiring a second biosignal evoked by recognition of the surrounding information from the user, setting a driving direction of the moving body, commanding the moving body to automatically perform a driving operation to be carried out in the set driving direction, and acquiring a third biosignal responsive to recognition of a driving error from the user and correcting the driving direction of the moving body to induce driving path resetting.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: June 27, 2023
    Assignee: Korea Institute of Science and Technology
    Inventors: Laehyun Kim, Da-Hye Kim, Seung-jun Oh, Eon Jo Hong
  • Patent number: 11250121
    Abstract: A method of operating a storage device that is connected to a host includes entering an authentication mode; and performing the authentication operation responsive to entering the authentication mode. The performing of the authentication operation includes receiving a read command and a first random authentication address from the host; performing an authentication procedure based on at least a portion of the first random authentication address; and generating result data responsive to performing the authentication algorithm.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: February 15, 2022
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Hee-seok Hong, Seung-jun Oh, Se-min Yim
  • Publication number: 20220004184
    Abstract: The present disclosure relates to technology that controls a remote moving body based on collaboration between the moving body and human, and a method for controlling a moving body includes acquiring a first biosignal indicating an intention to start operation of the moving body from a user, operating the moving body, determining a surrounding situation of the moving body that autonomously controls the driving, providing the user with surrounding information of the moving body for inducing path setting, acquiring a second biosignal evoked by recognition of the surrounding information from the user, setting a driving direction of the moving body, commanding the moving body to automatically perform a driving operation to be carried out in the set driving direction, and acquiring a third biosignal responsive to recognition of a driving error from the user and correcting the driving direction of the moving body to induce driving path resetting.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 6, 2022
    Applicant: Korea Institute of Science and Technology
    Inventors: Laehyun KIm, Da-Hye Kim, Seung-jun Oh, Eon Jo Hong
  • Patent number: 10525151
    Abstract: A method for preparing a radiopharmaceutical and, specifically, a method for preparing an organic fluoride-aliphatic compound usable as a radiopharmaceutical, a method for purifying the prepared organic fluoride-aliphatic compound, and a method for preparing a radiopharmaceutical by using a cassette comprising a backdraft preventing reaction container. A method for preparing an organic fluorinated aliphatic compound includes allowing a fluorine salt to react with a leaving group-containing aliphatic compound by using a multifunctional solvent represented by the following Chemical Formula 1 to obtain an aliphatic compound labeled with [18F] fluoride substituting for the leaving group. The organic fluoride-aliphatic compound can be prepared and purified through even a simple process at high yield, high efficiency, and high purity, and the radiopharmaceutical can be safely prepared without damage to a synthetic apparatus.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: January 7, 2020
    Assignee: THE ASAN FOUNDATION
    Inventors: Sang-ju Lee, Seung-jun Oh, Dae-hyuk Moon, Jin-sook Ryu, Jae-seung Kim, Jong-jin Lee
  • Publication number: 20190213320
    Abstract: A method of operating a storage device that is connected to a host includes entering an authentication mode; and performing the authentication operation responsive to entering the authentication mode. The performing of the authentication operation includes receiving a read command and a first random authentication address from the host; performing an authentication procedure based on at least a portion of the first random authentication address; and generating result data responsive to performing the authentication algorithm.
    Type: Application
    Filed: January 4, 2019
    Publication date: July 11, 2019
    Inventors: Hee-seok Hong, Seung-jun Oh, Se-min YIM
  • Publication number: 20170319720
    Abstract: A method for preparing a radiopharmaceutical and, specifically, a method for preparing an organic fluoride-aliphatic compound usable as a radiopharmaceutical, a method for purifying the prepared organic fluoride-aliphatic compound, and a method for preparing a radiopharmaceutical by using a cassette comprising a backdraft preventing reaction container. A method for preparing an organic fluorinated aliphatic compound includes allowing a fluorine salt to react with a leaving group-containing aliphatic compound by using a multifunctional solvent represented by the following Chemical Formula 1 to obtain an aliphatic compound labeled with [18F] fluoride substituting for the leaving group. The organic fluoride-aliphatic compound can be prepared and purified through even a simple process at high yield, high efficiency, and high purity, and the radiopharmaceutical can be safely prepared without damage to a synthetic apparatus.
    Type: Application
    Filed: November 6, 2015
    Publication date: November 9, 2017
    Inventors: Sang-ju LEE, Seung-jun OH, Dae-hyuk MOON, Jin-sook RYU, Jae-seung KIM, Jong-jin LEE
  • Patent number: 9133143
    Abstract: The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to ?-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: September 15, 2015
    Assignee: FUTURECHEM CO., LTD.
    Inventors: Dae-Yoon Chi, Byoung-Se Lee, Sirion Uthaiwan, So-Young Chu, Yu-Jin Bae, Chansoo Park, Dae-Hyuk Moon, Jin-Sook Ryu, Jae-Seung Kim, Seung-Jun Oh
  • Publication number: 20120214994
    Abstract: The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to ?-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 23, 2012
    Inventors: Dae-Yoon Chi, Byoung-Se Lee, Sirion Uthaiwan, So-Young Chu, Yu-Jin Bae, Chansoo Park, Dae-Hyuk Moon, Jin-Sook Ryu, Jae-Seung Kim, Seung-Jun Oh
  • Patent number: 6899128
    Abstract: A half ball valve includes a body including cavity having an assembly opening, a stem opening formed at a side of the body opposite to the assembly opening to connect the cavity and the outside, and a first connection hole inclined with respect to an axis of the stem opening. A ball is accommodated in the cavity of the body through the assembly opening to be capable of rotating to switch between an open position at which the first connection hole is open and a close position at which the first connection hole is blocked. A passage is formed in the ball inclined with respect to an axis of the stem opening and is connected to the first connection hole at the open position. A stem connects a control lever outside the body and the ball along the stem opening. A body cap having a second connection hole connected to the passage of the ball is coupled to the body to cover the cavity at the assembly opening side. A packing is interposed between an outer surface of the ball and an inner wall of the body.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: May 31, 2005
    Inventor: Seung-Jun Oh
  • Publication number: 20030217771
    Abstract: A half ball valve includes a body including cavity having an assembly opening, a stem opening formed at a side of the body opposite to the assembly opening to connect the cavity and the outside, and a first connection hole inclined with respect to an axis of the stem opening. A ball is accommodated in the cavity of the body through the assembly opening to be capable of rotating to switch between an open position at which the first connection hole is open and a close position at which the first connection hole is blocked. A passage is formed in the ball inclined with respect to an axis of the stem opening and is connected to the first connection hole at the open position. A stem connects a control lever outside the body and the ball along the stem opening. A body cap having a second connection hole connected to the passage of the ball is coupled to the body to cover the cavity at the assembly opening side. A packing is interposed between an outer surface of the ball and an inner wall of the body.
    Type: Application
    Filed: November 8, 2002
    Publication date: November 27, 2003
    Inventor: Seung-Jun Oh
  • Publication number: 20030120046
    Abstract: The present invention relates to a complex comprising one or more radioisotopes selected from the group consisting of 99mTc, 188Re and 186Re chelated to a glucose derivative having an intramolecular nitrogen or sulfur atom, which is very useful as tumor diagnostic agents. It also relates to a kit for the preparation thereof comprising the glucose derivative and a reducing agent.
    Type: Application
    Filed: September 20, 2002
    Publication date: June 26, 2003
    Inventors: Hee-Kyung Lee, Dae-Hyuk Moon, Jin-Sook Ryu, Jae-Seung Kim, Seung-Jun Oh
  • Patent number: D478373
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: August 12, 2003
    Inventor: Seung-Jun Oh